Kiromic BioPharma

+$0.04 (+0.50%) Today
-$0.24 (-2.99%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell KRBP and other stocks, options, and ETFs commission-free!

About KRBP

Kiromic Biopharma, Inc. operates as a biotechnology company, which engages in the development of cancer engineered immunotherapies. Its technologies include Intelligent Immunotherapy, Diamond AI, CancerSplice, ABBIE, and CAR-T Proprietary Binder Technology.

CEO
Maurizio Chiriva-Internati
Employees
—
Headquarters
Houston, Texas
Founded
2006

KRBP Key Statistics

Market Cap
63.67M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
6.01K
High Today
$8.04
Low Today
$7.51
Open Price
$7.67
Volume
1.75K
52 Week High
$18.50
52 Week Low
$7.51

KRBP Earnings

-$0.65
-$0.43
-$0.22
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 17

You May Also Like

MBINO
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure